| Literature DB >> 17618860 |
Alan J A McBride1, Fernanda A Pereira, Emilson D da Silva, Rosan B de Matos, Edimilson D da Silva, Antônio G P Ferreira, Mitermayer G Reis, Albert I Ko.
Abstract
Access to low-cost, effective diagnosis for leptospirosis is urgently needed in developing countries. The EIE-IgM-Leptospirose, a kit produced for public health laboratories in Brazil, was shown to have a sensitivity of 76% (77 of 102 patients) and 100% (102 of 102 patients) during acute and convalescent-phase leptospirosis, respectively, and a specificity of 93-100% (total healthy and patient control subjects evaluated, 486). These findings indicate that the assay will be useful for diagnosis of this emerging infectious disease in Brazil and other developing countries.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17618860 PMCID： PMC1994159 DOI： 10.1016/j.actatropica.2007.05.002
Source DB: PubMed Journal: Acta Trop ISSN： 0001-706X Impact factor: 3.112